1,685 Shares in Xylem Inc. $XYL Acquired by Optimize Financial Inc

Optimize Financial Inc acquired a new position in shares of Xylem Inc. (NYSE:XYL) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,685 shares of the industrial products company’s stock, valued at approximately $201,000.

Several other hedge funds and other institutional investors have also bought and sold shares of XYL. Price T Rowe Associates Inc. MD boosted its stake in Xylem by 689.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock worth $443,074,000 after acquiring an additional 3,239,203 shares during the last quarter. Nuveen LLC bought a new position in Xylem during the 1st quarter worth approximately $99,726,000. OVERSEA CHINESE BANKING Corp Ltd boosted its stake in Xylem by 390.5% during the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company’s stock worth $122,009,000 after acquiring an additional 813,100 shares during the last quarter. Vaughan Nelson Investment Management L.P. bought a new position in Xylem during the 1st quarter worth approximately $89,828,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Xylem during the 4th quarter worth approximately $83,139,000. Institutional investors own 87.96% of the company’s stock.

Insider Buying and Selling at Xylem

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the transaction, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company’s stock.

Xylem Price Performance

NYSE XYL opened at $137.48 on Wednesday. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $145.33. The company has a market capitalization of $33.46 billion, a PE ratio of 35.71, a price-to-earnings-growth ratio of 2.42 and a beta of 1.09. The firm’s 50 day moving average is $137.70 and its 200-day moving average is $127.36.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.20 billion. During the same period last year, the company earned $1.09 earnings per share. The firm’s revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Equities research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.2%. Xylem’s dividend payout ratio (DPR) is currently 41.56%.

Analyst Ratings Changes

Several research firms recently weighed in on XYL. Raymond James Financial raised shares of Xylem to a “hold” rating in a research note on Thursday, May 15th. UBS Group raised their target price on shares of Xylem from $164.00 to $168.00 and gave the stock a “buy” rating in a report on Tuesday, August 5th. Cowen restated a “hold” rating on shares of Xylem in a report on Tuesday, August 26th. Wall Street Zen upgraded shares of Xylem from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. Finally, Stifel Nicolaus raised their target price on shares of Xylem from $162.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Six investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $152.29.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.